Simplify Logo

Internship

Summer 2025 – Pharmaceutical Candidate Optimization and Nonclinical Safety/Veterinary Sciences Inte…

Updated on 10/5/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Compensation Overview

$21 - $29Hourly

Boston, MA, USA + 5 more

More locations: Seattle, WA, USA | Summit, NJ, USA | Franklin Township, NJ, USA | Princeton, NJ, USA | San Diego, CA, USA

Roles may require 50% or more onsite presence depending on the occupancy type.

Category
Veterinary Professionals
Medical, Clinical & Veterinary
Requirements
  • Undergraduate student, enrolled in an academic program for the Fall of 2025, with demonstrated interest and effort within biology, chemistry, toxicology, computational sciences, pharmaceutical sciences, material sciences, biomedical engineering, veterinary science and related disciplines.
  • Undergraduate student should have continued interest in pursuing academic endeavors or a career in the sciences after graduation.
  • Availability for full-time employment (40 hrs/week) throughout the 10-week internship period of June 2, 2025 to August 8, 2025.
Responsibilities
  • Directly contribute to assigned project with manager support, which is aligned with PCO and NCS/VS responsibilities and student experiences/goals.
  • Responsibilities will vary with assigned project, but can include laboratory work, literature/data review, use of AI tools, computer programming and/or computational analyses.
  • Active participation in informal networking/mentor meetings and formal symposiums.
  • Presentation of overall project and scientific findings at the conclusion of the internship.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs, providing affordable alternatives that maintain the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while adhering to sustainability and corporate responsibility principles.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.